Browsing Category

Supplier News

196 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Vetter Outlines Major Expansion Plan for Commercial & Clinical Fill–Finish 
By

By
Lars Hahn, Senior Vice President, Global Sales Organization, Vetter Pharma International GmbH, a CDMO of drug product development, clinical, and commercial aseptic filling and packaging, outlined major expansions to increase the company’s…

Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing 
By

By
Lonza is proceeding with multiple investments in its core CDMO business to increase capacity in large-scale biomanufacturing, bioconjugation, and drug-product manufacturing. Stefan Egli, Business Unit Head, Mammalian, Lonza, provided an…

CordenPharma Investing More Than $1-Bn to Expand Peptide Production Capacity 
By

By
CordenPharma is advancing a more than EUR 1-billion ($1.1-billion) strategic investment in peptide development and manufacturing. Michael Quirmbach, PhD, CEO & President of CordenPharma, outlined the company’s expansion plans at…

Avantor Completes Multi-Year Expansion To Expand Global Hydration Capabilities 
By

By
Avantor has completed a multi-year expansion at its flagship European GMP manufacturing site in Gliwice, Poland, to increase its global hydration capabilities. Ger Brophy, Ph.D., Chair, Scientific Advisory Board, Avantor,…

FUJIFILM Diosynth Biotechnologies Advancing Multi-Billion Expansions in Biomanufacturing 
By

By
FUJIFILM Diosynth Biotechnologies is advancing two large-scale biomanufacturing expansions. Lars Petersen, CEO and President, FUJIFILM Diosynth Biotechnologies, outlined the company’s biomanufacturing expansions plans at the DCAT Member Company Announcement Forum…

BioDuro Expanding Drug-Substance Mfg, Peptide Scale-Up Capabilities 
By

By
BioDuro, an contract research, development, and manufacturing organization, is expanding its global network with the opening of a new drug-substance R&D and manufacturing campus in Bengbu, China, and the addition…

Thermo Fisher Highlights Expansions in Biomanufacturing, Sterile & Oral Solid Dose 
By

By
Throughout 2025, Thermo Fisher Scientific is investing in capacity and capabilities for drug-substances, drug products, clinical trial supply, and bioproduction. Jennifer Cannon, President, Commercial Operations, Pharma Services Business, Thermo Fisher,…

Axplora Adding New Facility for Purification of Peptides, Other APIs 
By

By
Axplora, a CDMO of small-molecule active pharmaceutical ingredients (APIs), antibody drug conjugates, and industrial chromatography, is investing EUR 50-million ($52-million) at its site in Mourenx, France, for a large-scale high-performance…

Esteve Targets Expansions in Spain and China 
By

By
Esteve is investing EUR 180 million ($199 million) to expand is small-molecule active pharmaceutical ingredient (API) manufacturing capacity in Europe and China. Daniel Calvo, Head of Business Account Management, Esteve,…

Symbiotec Pharmalab Expands Manufacturing Capabilities with Dual Chamber Vial Facility and Biomanufacturing Hub 
By

By
Symbiotec Pharmalab, a pharmaceutical company specializing in steroid and hormone active pharmaceutical ingredients, is advancing two major expansions to enhance its manufacturing capabilities: the launch of an injectable facility for…